| 3. MANUFACTURING OPERATIONS - ACTIVE SUBSTANCES |
Active Substance:ALFENTANIL HYDROCHLORIDE |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Purification with ketone/water. Crystallization
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:AMBRISENTAN |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Purification with isopropanol/water
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying and milling
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:CLOPERASTINE FENDIZOATE |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Purification with acetone
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying, screening and milling
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:fentanyl |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Dissolution in heptane, crystallization and filtration
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:FENTANYL CITRATE |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Formation of citric salt, crystallization, filtration and purification in ethanol
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying, micronization
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:menbutone |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Formation of sodium salt, precipitation, crystallization and purification in acetone
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying and screening
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:MEPTAZINOL HYDROCHLORIDE |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Purification with ethyl acetate / methanol
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying and screening
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:REMIFENTANIL HYDROCHLORIDE |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Formation hydrochloride salt, crystallization, extractions with toluene, butanone/methanol purificat
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:SUFENTANIL CITRATE |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Purification with 2-propanol
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|